

Background and Objective: A high body mass index (BMI) has many negative health consequences. Recurrent pregnancy loss (RPL) has become an important issue in pregnancy outcomes. An increasing frequency of RPL not only in undernourished women but also in women with high BMIs suggested that there is an association between these variables. Lack of evidence urged the authors to determine the association between RPL and high BMI to understand the correlation between RPL in women with high BMI so that BMI can be considered in the prevention of RPL with nutritional approaches. Materials and Methods: This evidence-based case report used the population, intervention, control, outcome (PICO) method in the literature search. A literature search was performed by hand searches and database searches in Cochrane Library, Science Direct and PubMed. The included articles were appraised for their results and quality assessment using the Center for Evidence Based Medicine (CEBM) Oxford Appraisal Tools. Results: We found 308 articles; however, only one meta-analysis was included in the qualitative analysis. The article concluded that there was a significant correlation between a high BMI and RPL (OR = 1.34 [95% CI, 1.05-1.70]; p = 0.02), especially in obese patients (OR = 1.75 [95% CI, 1.24-2.46]; p = 0.001). These results were in line with those of several studies and reviews. While remaining unclear, various factors are considered to cause RPL in obesity, such as abnormalities in the hormonal axis, oocyte quality, embryo development, endometrial receptivity and inflammation markers. Conclusion: A high BMI in pregnant women is significantly correlated with a higher incidence of recurrent pregnancy loss. Thus, comprehensive management of prenatal care including a nutritional approach is required to prevent RPL.
The body mass index (BMI) is a tool to measure the weight-to-height ratio of a person to classify their nutritional status. A high BMI can be classified as overweight or obesity. Overweight and obesity are defined as conditions of excessive accumulation of fat that may impair health1,2. The WHO1 European BMI classification defines overweight as a condition with a BMI of >25 kg m2, while obesity is defined as a condition with a BMI of >30 kg m2. However, the WHO has lowered the BMI cut-off in the Asian population to >23.5 kg m2 for overweight and >27 kg m2 for obesity.2
A high BMI, overweight and obesity are considered major problems in the modern age. While originally considered common in high-income countries, it has progressively affected low-to-middle-income countries, especially in urban areas. The change to a sedentary lifestyle and higher consumption has increased the prevalence of overweight and obesity. In 2016, there were 1.9 billion adults (>18 years old) and more than 640 million people with obesity. Obesity and overweight have rapidly increased since 1975 and continue to increase each year. The increasing prevalence of obesity and overweight has also been observed in Indonesia. Several studies have shown that the prevalence of overweight individuals has doubled from 17.1-33% between 1993 and 2014, while obesity affects 23.1% adults3,4.
Overweight and obesity have been linked to various comorbidities, with obesity at the center. Overweight and obesity are linked to increased risks of other metabolic diseases and a redeemed to be key players in metabolic syndrome pathophysiology, which leads to an increase in the mortality rate comparable to an increasing BMI5. Obesity is a known risk factor of cancer, type 2 diabetes mellitus, hypertension, stroke, coronary artery disease, etc5,6. One of the major pathophysiological changes in obesity is the distribution of excess weight and fat (adipocytes). The accumulation of adipocytes is known to play a role in insulin resistance, which is part of the natural history of various diseases, particularly diabetes mellitus5,6. Adipocytes also contribute to the increase in reactive oxygen species (ROS) and pro-inflammatory cytokines. This phenomenon then leads to the dysfunction of blood vessels, which can lead to coronary artery disease and stroke6. Apart from its impact on physical health, obesity also impacts both mental and social health, such as low self-esteem and mood disorders5.
In contrast to overweight and obesity, Lorem et al.7 defined the underweight as a BMI < 18.5 kg m2. In 2016, 8.9% of people globally were underweight. Southeast Asia is the region with the highest prevalence of underweight individuals, estimated at 20.3%8. Not only a high BMI but also a low BMI have adverse health effects. A BMI <18.5 kg m2 was reported to impair quality of life7. Studies have shown that being underweight increases the risk of cardiovascular diseases9. Psychologically, being underweight has been associated with depression10.
Both low BMI and high BMI are linked to several reproductive diseases and issues. Prepregnancy underweight status was found to have a greater risk of preterm birth, low birth weight and intrauterine growth restriction11. Being underweight can affect the development of the placenta in pregnant women and affect the growth of the fetus due to a lack of nutrients12. Obesity is linked to erectile dysfunction and impairment in the hormonal axis in males. Similar effects have been observed in females, particularly for infertility13,14. Obesity and overweight are known to impair the hormonal axis, which leads to anovulation. Insulin resistance plays a role in polycystic ovarian syndrome (PCOS), which leads to a decrease in the ovulation rate13. Overweight status and obesity are also correlated with an increased risk of pregnancy complications, especially gestational diabetes and preeclampsia and an increased rate of cesarean delivery14.
Both undernourishment and high BMI are correlated with infertility, including recurrent pregnancy loss (RPL). RPL is an important issue in reproductive health. It affects approximately 2-5% of couples. There are debates concerning the definition of RPL and how to diagnose it in patients. However, no consensus has been achieved. The American Society of Reproductive Medicine (ASRM) defines RPL as the loss of 2 or more pregnancies with a gestational age of less than 20 weeks15,16.
RPL has several etiologies. Anatomic defects, either acquired abnormalities, such as myomas and endometrial polyps, or congenital abnormalities, such as a bicornuate uterus, were found in 19% of women with RPL. Approximately 6-42% of women with RPL were reported to have antiphospholipid syndrome (APS). Endocrine factors also play a role in recurrent pregnancy loss. Hyperprolactinemia and hypothyroidism were found to be associated with RPL. However, the etiology of RPL in some couples is unknown. Quick evaluation and management after a 2nd pregnancy loss are required to prevent RPL. The workup and management of RPL have been heavily targeted to treat genetic factors, uterine anatomy defects and autoimmune diseases. The treatment is focused on each known etiology. RPL with unknown etiologies is managed using an empirical treatment, such as progestin-only pills to strengthen the pregnancy17..
RPL might not be considered a comorbidity in mothers but a significant psychological factor that might affect the patient’s functionality and mental health. Women with RPL have a good prognosis of being able to maintain their next pregnancy and have a healthy live birth. This outcome can be achieved by managing the etiology of the previous pregnancy losses and is supported by the mother having a healthy lifestyle. Body mass index is one of many environmental factors that need to be paid attention during pregnancy15.
Obesity has been found to increase maternal and fetal morbidity during pregnancy17. Therefore, the authors wanted to determine the connection between high BMI and RPL so that BMI can be considered in the prevention of RPL. A nutritional approach is expected to help decrease the rate of RPL. Therefore, the authors conducted an Evidence-Based Case Report (EBCR) to objectively review several pieces of literature and determine the connection between high BMI and RPL.
CASE REPORTA 26-year-old G3P0A2 female at 21 weeks of gestation was transferred to the delivery room due to active bleeding from the birth canal followed by strong and painful contractions. After the examination, she was unsuccessfully managed on tocolytic medications and tranexamic acid. A normal vaginal birth was conducted and a baby girl with a weight of 550 g was born. However, the baby died during her transfer to the NICU. The patient had two previous abortions at 16 and 18 weeks of pregnancy.
The patient had a BMI of 31 kg m2. She and her husband asked the physician whether her nutritional status according to her BMI, in addition to other risk factors, increased her risk of recurrent pregnancy loss.
CLINICAL QUESTIONIn pregnant women with a history of pregnancy loss, does high body mass index increase the risk of recurrent pregnancy loss?
Search strategy and screening process: We used the PICO model to describe our clinical question for the search query used in every database. The PICO was pregnant women with a history of pregnancy loss (population), high BMI/overweight/obesity (intervention), normal BMI (comparison) and recurrent pregnancy loss/recurrent miscarriage (outcome). The literature search was conducted in three databases: Cochrane Library, Science Direct and PubMed. In each of these databases, we used Boolean terms to incorporate our PICO model using the key terms “pregnant women”, “obesity” and “recurrent pregnancy loss”, which were then combined for the literature search including their synonyms and MeSH terms. The used terms and keywords for our search query are summarized in Table 1.
Eligibility criteria: Prior to the literature search, we determined the inclusion and exclusion criteria used in this review. The inclusion criteria are listed below:
The studies excluded from this study are listed below:
Our screening process was performed using these criteria by evaluating the titles, abstracts and full text of the articles to determine their PICO parameters and study designs.
Critical appraisal and quality assessment: The critical appraisal process was performed using the Center of Evidence Based Medicine (CEBM) Oxford Appraisal Tools of Systematic Review18. The appraisal process was separately performed by each author. Disputes among the authors were resolved by discussion. Quality assessment was subjectively performed by each author before finalizing the assessment.
A total of 307 articles were found in the selected databases and screened based on the eligibility criteria in this review. No articles were eligible for the appraisal process. The reasons for exclusion of the remaining articles were as follows: 271 articles were not related to a high BMI and RPL, 14 articles were not specific to RPL, 21 articles were not specific to a high BMI and 1 article did not match the study type. A hand search was conducted to complement our literature search and one article was included in this study. An appraisal of one systematic review was conducted for study analysis. The condition of very limited resources and research conducted on this topic, especially in the last 10 years, limited our evidence-based analysis of this topic. The details and flowchart for the article selection process are shown in Fig. 1. The details of the article appraised in this study are shown in Table 2.
We conducted a critical appraisal of a systematic review by Cavalcante et al.19 using the CEBM Oxford appraisal tools and the results are shown in Table 318. The article used a similar PICO to that of this study and was determined to have an appropriate search strategy. The study used a total of six articles, which consisted of one case-control and five observational/cohort studies. We concluded that Cavalcante et al.19 included suitable study types for this particular topic. The classification of BMI used in the study was based on the WHO classification, which was also used by the individual studies included. It classifies women in a low-weight group (BMI, <18.5 kg m2), a normal weight group (BMI, 18.5-24.9 kg m2), an overweight group (BMI, 25.0-29.9 kg m2) and an obesity group (BMI, >30.0 kg m2). RPL was defined traditionally as the loss of two or more consecutive pregnancies with a gestational age of less than 24 weeks19.
While Cavalcante et al.19 included 6 articles for their appraisal and analysis, there were only 2 articles that were then used in the meta-analysis. A total of 7,805 women with RPL were included in all studies to be evaluated for subsequent pregnancy loss. There were 4 studies20-23 whose results demonstrated an increased risk of RPL in overweight and obese women. The case-control and prospective cohort
studies of declared an odds ratio (OR) and relative risk (RR) >1; hence, the RPL incidence significantly correlated with a high BMI15. In contrast, a study by Bhandari et al.24 declared that obese women had a better fertility rate and higher cumulative pregnancy rate than women of normal weight. Cavalcante et al19. then proceeded to conduct a quantitative analysis using the studies of Metwally et al.21 and Lo et al.22 as the only two studies with sufficient data for the meta-analysis. Cumulative statistical analysis of both the studies conducted by Metwaly et al.21 and Lo et al.22 revealed a correlation between recurrent pregnancy loss and a high BMI. An analysis of overweight and obesity vs normal weight revealed a significant comparison between the two of them (OR = 1.34 [95% CI, 1.05-1.70]; p = 0.02). However, an isolated analysis revealed that only obesity significantly correlated with a higher risk of RPL. Cavalcante et al.19 concluded that there is a higher risk of RPL in women with a high BMI based on a literature review and meta-analysis.
These results are in line with those of a case-control study conducted by Zhang et al.25 that evaluated the correlation between BMI and the incidence of recurrent spontaneous pregnancy loss. Zhang et al.25 found a significant correlation between BMI >24 kg m2 and RSM (OR = 1.54 [95% CI, 1.12-2.14]). An isolated analysis also reported a significant correlation between a BMI of >24 kg m2 and 3 pregnancy losses25. Similar results have also been reported by Metwally et al.21, who observed 16,000 patients. There was a significant increase in the pregnancy loss rates in women with a BMI >25 kg m2 (OR = 1.67; [95% CI, 1.25-2.25)26. A review by Talmor and Dunphy27 observed ovulation induction in overweight and obese patients. There was a significant increase in pregnancies after receiving an oocyte donation (OR = 1.52 [95% CI, 1.10-2.09]) and ovulation induction (OR = 5.11 [95% CI: 1.76-14.83]), especially in obese patients (OR = 4.68; [95% CI: 1.21-18.13]).27 These phenomena imply a decrease in the fertility rate in patients with a high BMI. The findings of a systematic review by Boots and Stephenson28, who observed 20,946 women, including 3,800 obese women and 17,146 normal weight women, agreed with these findings. A pooled analysis revealed a significant correlation between a high BMI and RPL (OR = 1.31 [95% CI: 1.18-1.46])28. While the results remain unclear, factors affecting the increasing rate of RPL in patients with a high BMI could be inferred from several studies that reported a similar trend. In 2007, Metwally et al.21 reported the impact of BMI on endometrial morphology and the peri-implantation period and concluded that there was a significant effect on endometrial steroids and leukocytes (r = −0.4, p = 0.02)29. Arendas et al.30 also reported an increasing risk of preconception and post conception consequences, including pregnancy loss, in women with a high BMI30.
Nutrition is an important aspect in pregnancy to determine long-term health of the mother and the fetus. It is imperative that a pregnant mother has more nutritional intake; thus, women who are pregnant are encouraged to eat more and women that are planning pregnancies “stock up” on nutrition for the fetus. Malnutrition during pregnancy in low- and middle-income countries is the most prominent factor of maternal death and disabilities. The health of not only the mother but also the fetus is affected by malnutrition. The increasing nutritional needs for mothers during pregnancy can make maternal undernutrition very harmful for both the mother and the infant.
Maternal undernutrition can lead to low birth weight, serious damage to fetal development, preterm birth, or other unsuccessful birth outcomes. Micronutrient deficiencies, such as folate, vitamin B6, vitamin B12, vitamin C, zinc and iron, have serious impacts, one of which is spontaneous abortion31,32. Thoughts about the dangers of underweight mothers in pregnancy are quite obvious but the risk of overweight and obesity in pregnancy is not to be underestimated. Overweight and obesity are commonly associated with complications, such as preeclampsia, preterm birth, or gestational diabetes. They also might correlate with RPL33.
The results of an appraised systematic review by Cavalcante et al.19 agree with those of a previous study by Sugiura-Ogasawara34 who concluded that BMI >30 kg m2 is an independent risk factor of RPL. Obesity increases the susceptibility of patients with RPL to further pregnancy loss. A similar result was found in the ESHRE guideline35 on RPL. This guideline mentioned the strong association between maternal obesity and negative impact on the chances of live birth and that lifestyle modification, especially having a normal BMI, is relevant for reducing the risk of RPL34,35.
Obesity is a risk condition of health that contributes to the etiology of many reproductive issues, including RPL. Obese patients commonly have poorer fertility prognoses compared to normal BMI controls. The mechanism behind the higher risk of RPL in patients with obesity remains unclear. Cavalcante et al.19 mentioned that RPL in obese patients is associated with abnormalities in the hypothalamic-pituitary-gonadal hormonal axis and obesity directly affects oocyte quality, embryo development and endometrial receptivity. A study by Pearson and Mahmood36 also showed that obesity affects oocyte quality and endometrial development and Bahadur and Chaturvedi37 explained that endocrine changes in obese patients results in embryo viability.
Cavalcante et al.19 explained the effects on oocyte quality and analyzed the assisted reproduction outcome based on BMI. This study showed that obese patients have significantly fewer mature oocytes than non-obese patients19. Obesity also affects endometrial receptivity even though the precise mechanism is still not fully understood. In addition, obese patients experience changes in the secretion of ghrelin, leptin, resist in and adiponectin. Alterations in the secretion of these hormones affects early embryo development and implantation. The quality of oocytes and the receptivity of the endometrium during embryo development and the implantation window are important components of good fertilization, resulting in a higher risk of RPL in patients with obesity36.
Although, it is more often used in explaining the association of RPL in patients with polycystic ovarian syndrome (PCOS), one of the mechanisms for the relationship between obesity and RPL is insulin resistance. In hyperinsulinemia, plasminogen activator inhibitor-1 (PAI-1) increases. Another mechanism in obese patients that could cause RPL is chronic inflammation. Not only the increase in PAI-1 but also increases in C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor-alpha have been shown. These inflammatory markers have harmful effects on the reproductive cycle and are associated with RPL27,36.
Looking at the association between obesity and RPL from a nutritional perspective, a dietary plan is one of the ways to reduce the risk of RPL. Weight reduction targeting a normal BMI is a rational recommendation to improve the pregnancy outcomes in obese patients with RPL. Based on a nutritional approach, a protein-rich and very low-calorie diet are useful to reduce PAI-1 activity and improve insulin sensitivity. Dietary components that increase the levels of inflammatory markers, such as large amounts of high-fat dairy, red meat, or simple carbohydrates, should be avoided in obese patients with RPL. Obese patients with RPL should find diets that lower inflammatory markers that increase in RPL patients, such as the Mediterranean diet. This dietary plan consists of fish, fruits, leafy greens and grains, which are associated with low amounts of inflammatory markers. Even though the evidence of this dietary plan is not strong enough to be a dietary plan in patients with RPL, it is still healthy, is aligned with weight loss and has low inflammatory markers. A study by Vahid et al.38 also concluded that consuming a more pro-inflammatory diet has a higher risk of pregnancy loss than consuming an anti-inflammatory diet. Nevertheless, comprehensive approaches, such as exercise and pharmacology (insulin-sensitizing agents, immunological agents, or supplementation with progesterone therapy), need to be considered19,27,36.
High BMI is correlated with the incidence of recurrent pregnancy loss, whereas pregnant women with BMIs of 25.0-29.9 kg m2 are not. The mechanism of recurrent pregnancy loss in women with obesity is unclear; possible mechanisms are disturbances in the hypothalamic-pituitary-gonadal hormonal axis, oocyte quality, endometrial receptivity and inflammatory markers. In clinical settings, we recommend a comprehensive approach in the antenatal care of pregnant women with obesity to undergo nutritional assessment and management, hoping to reduce the probability of recurrent pregnancy loss.
This research was not funded by any means and was fully supported by the Department of Obstetrics and Gynecology of Faculty of Medicine Universitas Indonesia.